CE‐MS‐based proteomics in biomarker discovery and clinical application
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
CE‐MS is applied in clinical proteomics for both the identification of biomarkers of disease and assessment of biomarkers in clinical diagnosis. The analysis is reproducible, fast, and requires only small sample volumes. However, successful CE‐MS analysis depends on several critical steps that can be consolidated as follows: (i) proper sample preparation and fractionation, (ii) application of suitable capillary coating and appropriate CE‐MS interfaces, to ensure the reproducibility and stability of the analysis, and (iii) an optimized clinical and statistical study design to increase the chances for obtaining clinically relevant results. In this review, we cover all these aspects, and present several examples of the application of CE‐MS in clinical proteomics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
Good, D. M., Zürbig, P., Argilés, À., Bauer, H. W., Behrens, G., Coon, J. J., Dakna, M., Decramer, S., Delles, C., Dominiczak, A. F., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.001917 · Cited by 524
Self-citationPolymer wall coatings for capillary electrophoresis
Horvath, J., & Dolník, V. (2001) · ELECTROPHORESIS · doi:10.1002/1522-2683(200102)22:4<644::aid-elps644>3.0.co;2-3 · Cited by 492
Decramer, S., de Peredo, A. G., Breuil, B., Mischak, H., Monsarrat, B., Bascands, J.-L., & Schanstra, J. P. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800001-mcp200 · Cited by 450
Self-citationTranslation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges
Füzéry, A. K., Levin, J., Chan, M. M., & Chan, D. W. (2013) · Clinical Proteomics · doi:10.1186/1559-0275-10-13 · Cited by 428
On-line sample preconcentration in capillary electrophoresis
Simpson, S. L., Quirino, J. P., & Terabe, S. (2008) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.11.001 · Cited by 342
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
Mischak, H., Allmaier, G., Apweiler, R., Attwood, T., Baumann, M., Benigni, A., Bennett, S. E., Bischoff, R., Bongcam-Rudloff, E., Capasso, G., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001249 · Cited by 334
Self-citationMoini, M. (2007) · Analytical Chemistry · doi:10.1021/ac0704560 · Cited by 322
Clinical proteomics: A need to define the field and to begin to set adequate standards
Mischak, H., Apweiler, R., Banks, R. E., Conaway, M., Coon, J., Dominiczak, A., Ehrich, J. H. H., Fliser, D., Girolami, M., Hermjakob, H., et al. (2007) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.200600771 · Cited by 307
Self-citationListgarten, J., & Emili, A. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r500005-mcp200 · Cited by 299
Kolch, W., Neusüß, C., Pelzing, M., & Mischak, H. (2005) · Mass Spectrometry Reviews · doi:10.1002/mas.20051 · Cited by 290
Self-citation
Research works printed but not linked: 1
- 10.1080/10408360902805261 · DOI
Cited by
Wanner, P. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2020.128453 · Cited by 183
Recent developments in capillary and microchip electroseparations of peptides (2011–2013)
Kašička, V. (2013) · Electrophoresis · doi:10.1002/elps.201300331 · Cited by 137
Next-generation capillary electrophoresis–mass spectrometry approaches in metabolomics
Zhang, W., Hankemeier, T., & Ramautar, R. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.07.002 · Cited by 128
Cisek, K., Krochmal, M., Klein, J., & Mischak, H. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv364 · Cited by 127
Self-citationContemporary hydrogen deuterium exchange mass spectrometry
Oganesyan, I., Lento, C., & Wilson, D. J. (2018) · Methods · doi:10.1016/j.ymeth.2018.04.023 · Cited by 137
Recent trends of capillary electrophoresis‐mass spectrometry in proteomics research
Gomes, F. P., & Yates, J. R. (2019) · Mass Spectrometry Reviews · doi:10.1002/mas.21599 · Cited by 112
Frantzi, M., van Kessel, K. E., Zwarthoff, E. C., Márquez, M., Rava, M., Malats, N., Merseburger, A. S., Katafigiotis, I., STRAVODIMOS, K. G., Mullen, W., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2715 · Cited by 106
Self-citationRecent advances in CE‐MS coupling: Instrumentation, methodology, and applications
Týčová, A., Ledvina, V., & Klepárník, K. (2017) · ELECTROPHORESIS · doi:10.1002/elps.201600366 · Cited by 99
CE–MS for metabolomics: Developments and applications in the period 2014–2016
Ramautar, R., Somsen, G. W., & de Jong, G. J. (2016) · Electrophoresis · doi:10.1002/elps.201600370 · Cited by 93
Proteomics biomarkers for solid tumors: Current status and future prospects
Belczacka, I., Latosińska, A., Metzger, J., Marx, D., Vlahou, A., Mischak, H., & Frantzi, M. (2018) · Mass Spectrometry Reviews · doi:10.1002/mas.21572 · Cited by 83
Self-citationŠtěpánová, S., & Kašička, V. (2015) · Journal of Separation Science · doi:10.1002/jssc.201500973 · Cited by 71
Recent developments in capillary and microchip electroseparations of peptides (2013–middle 2015)
Kašička, V. (2015) · Electrophoresis · doi:10.1002/elps.201500329 · Cited by 69
Mermelekas, G., Vlahou, A., & Zoidakis, J. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1093937 · Cited by 73
Self-citationCapillary zone electrophoresis-mass spectrometry for bottom-up proteomics
Zhang, Z., Qu, Y., & Dovichi, N. J. (2018) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.08.008 · Cited by 61
Coupling of CE‐MS for protein and peptide analysis
Mikšík, I. (2018) · Journal of Separation Science · doi:10.1002/jssc.201800817 · Cited by 64
Faserl, K., Chetwynd, A. J., Lynch, I., Thorn, J. A., & Lindner, H. (2019) · Nanomaterials · doi:10.3390/nano9060898 · Cited by 60
Capillary Electrophoresis–Mass Spectrometry for Clinical Metabolomics
Ramautar, R. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.12.002 · Cited by 65
Sample preparation and fractionation techniques for intact proteins for mass spectrometric analysis
Thomas, S. L., Thacker, J. B., Schug, K. A., & Maráková, K. (2020) · Journal of Separation Science · doi:10.1002/jssc.202000936 · Cited by 64
Li, X., Ma, Q., Zheng, X., Chen, Q., & Sun, X. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.01.003 · Cited by 56
de Koster, N., Clark, C., & Köhler, I. (2020) · Electrophoresis · doi:10.1002/elps.202000151 · Cited by 63
Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS
Mavrogeorgis, E., Mischak, H., Latosińska, A., Siwy, J., Jankowski, V., & Jankowski, J. (2021) · Molecules · doi:10.3390/molecules26237260 · Cited by 49
Self-citationŠtěpánová, S., & Kašička, V. (2018) · Journal of Separation Science · doi:10.1002/jssc.201801090 · Cited by 59
Recent developments in capillary and microchip electroseparations of peptides (2015–mid 2017)
Kašička, V. (2017) · Electrophoresis · doi:10.1002/elps.201700295 · Cited by 53
Proteomics in cardiovascular disease: recent progress and clinical implication and implementation
Mokou, M., Lygirou, V., Vlahou, A., & Mischak, H. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1274653 · Cited by 51
Self-citationThe long path towards implementation of clinical proteomics: Exemplified based on CKD273
Nkuipou‐Kenfack, E., Zürbig, P., & Mischak, H. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201600104 · Cited by 49
Self-citationAdvances in diagnostics for transplant rejection
Nasr, M., Sigdel, T. K., & Sarwal, M. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1239530 · Cited by 52
Chetwynd, A. J., Guggenheim, E. J., Briffa, S. M., Thorn, J. A., Lynch, I., & Valsami‐Jones, E. (2018) · Nanomaterials · doi:10.3390/nano8020099 · Cited by 46
Maráková, K., Opetová, M., & Tomašovský, R. (2023) · Journal of Separation Science · doi:10.1002/jssc.202300244 · Cited by 45
Capillary zone electrophoresis for bottom‐up analysis of complex proteomes
Sun, L., Zhu, G., Yan, X., Zhang, Z., Wojcik, R., Champion, M. M., & Dovichi, N. J. (2016) · PROTEOMICS · doi:10.1002/pmic.201500339 · Cited by 41
Urinary Peptidomic Biomarkers in Kidney Diseases
Sirolli, V., Pieroni, L., Liberato, L. D., Urbani, A., & Bonomini, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010096 · Cited by 46
Clinical applications of MS‐based protein quantification
Sabbagh, B., Mindt, S., Neumaier, M., & Findeisen, P. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500116 · Cited by 45
Recent advances in CE and microchip‐CE in clinical applications: 2014 to mid‐2017
Phillips, T. M. (2017) · Electrophoresis · doi:10.1002/elps.201700283 · Cited by 36
Evaluation of a new low sheath-flow interface for CE-MS: CE and CEC
González‐Ruiz, V., Codesido, S., Far, J., Rudaz, S. L., & Schappler, J. (2016) · Electrophoresis · doi:10.1002/elps.201500523 · Cited by 36
Clinical Proteomics: Closing the Gap from Discovery to Implementation
Frantzi, M., Latosińska, A., Kontostathi, G., & Mischak, H. (2018) · PROTEOMICS · doi:10.1002/pmic.201700463 · Cited by 35
Self-citationCapillary electrophoresis-mass spectrometry in pharmaceutical and biomedical analyses
Seyfinejad, B., & Jouyban, A. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.115059 · Cited by 34
Urinary proteomics can define distinct diagnostic inflammatory arthritis subgroups
Siebert, S., Porter, D. R., Paterson, C., Hampson, R., Gaya, D. R., Latosińska, A., Mischak, H., Schanstra, J. P., Mullen, W., & McInnes, I. B. (2017) · Scientific Reports · doi:10.1038/srep40473 · Cited by 37
Self-citationSiwy, J., Klein, T., Rosler, M., & von Eynatten, M. (2019) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800144 · Cited by 32
Recent advances of capillary electrophoresis-mass spectrometry instrumentation and methodology
Jiang, Y., He, M.-Y., Zhang, W.-J., Luo, P., Guo, D., Fang, X., & Xu, W. (2017) · Chinese Chemical Letters · doi:10.1016/j.cclet.2017.05.008 · Cited by 30
L’Imperio, V., Smith, A. J., Chinello, C., Pagni, F., & Magni, F. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500075 · Cited by 31
Recent applications of CE‐ and HPLC‐MS in the analysis of human fluids
Iadarola, P., Fumagalli, M., Bardoni, A., Salvini, R., & Viglio, S. (2015) · Electrophoresis · doi:10.1002/elps.201500272 · Cited by 29
Torati, L. S., Migaud, H., Doherty, M. K., Siwy, J., Mullen, W., Mesquita, P. E. C., & Albalat, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186692 · Cited by 26
Self-citationUrinary Glycopeptide Analysis for the Investigation of Novel Biomarkers
Belczacka, I., Pejchinοvski, M., Krochmal, M., Magalhães, P., Frantzi, M., Mullen, W., Vlahou, A., Mischak, H., & Jankowski, V. (2018) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800111 · Cited by 22
Self-citationMühlen, C. V. Z., Koeck, T., Schiffer, E., Sackmann, C., Zürbig, P., Hilgendorf, I., Reinöhl, J., Rivera, J., Zirlik, A., Hehrlein, C., et al. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500105 · Cited by 22
Self-citationApplications of multiple reaction monitoring targeted proteomics assays in human plasma
Kontostathi, G., Makridakis, M., Zoidakis, J., & Vlahou, A. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1615448 · Cited by 22
Self-citationPersson, F., & Rossing, P. R. (2019) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800176 · Cited by 20
A robust sheath‐flow CE‐MS interface for hyphenation with Orbitrap MS
Sauer, F., Sydow, C., & Trapp, O. (2020) · Electrophoresis · doi:10.1002/elps.202000044 · Cited by 21
(2022) · doi:10.3390/proteomes10030026 · Cited by 20
Simultaneous Identification of Vitamins B1, B3, B5, and B6 by an Engineered Nanopore
Ouyang, Y., Wang, K., Jia, W., Zhang, P., & Huang, S. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c03329 · Cited by 17
González‐Ruiz, V., Codesido, S., Rudaz, S. L., & Schappler, J. (2017) · Electrophoresis · doi:10.1002/elps.201700328 · Cited by 17
Progress Toward a Multiomic Understanding of Traumatic Brain Injury: A Review
Kocheril, P. A., Moore, S. C., Lenz, K. D., Mukundan, H., & Lilley, L. M. (2022) · Biomarker Insights · doi:10.1177/11772719221105145 · Cited by 17
CE-MS for Proteomics and Intact Protein Analysis
Kuzyk, V., Somsen, G. W., & Haselberg, R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-77252-9_4 · Cited by 15
CE-MS in Metabolomics: Status Quo and The Way Forward
Ramautar, R. (2016) · Bioanalysis · doi:10.4155/bio-2016-0001 · Cited by 13
Chromiec, A., Ordon, K., & Wietecha‐Posłuszny, R. (2023) · Green Analytical Chemistry · doi:10.1016/j.greeac.2023.100063 · Cited by 12
Mehl, B. T., & Martin, R. S. (2017) · Analytical Methods · doi:10.1039/c7ay02505j · Cited by 12
Deng, T., Liu, Y., Gael, A., Fu, X., Deng, X., Liu, Y., Wu, Y., Wu, Y., Wang, H., Deng, Y., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.862732 · Cited by 11
Techniques for Detection and Extraction of Metabolites
Gupta, P., Gupta, S., & Pruthi, V. (2020) · Springer eBooks · doi:10.1007/978-981-15-2604-6_3 · Cited by 10
Cell surface proteomics: Analytical challenges and clinical applications in cancer
Laurent, A., Allard, A., & Fillet, M. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118143 · Cited by 9
Siwy, J., Ahonen, L. L., Magalhães, P., Frantzi, M., & Rossing, P. R. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9841-8_18 · Cited by 8
Romson, J., Jacksén, J., & Emmer, Å. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.11.021 · Cited by 10
Kellie, J. F., Sikorski, T. W., An, B., Chen, Z., Moghieb, A. H., Busz, M., Szapacs, M. E., & Angel, T. E. (2019) · Bioanalysis · doi:10.4155/bio-2019-0191 · Cited by 8
Detection of telomerase activity using microchip electrophoresis
Karasawa, K., & Arakawa, H. (2015) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.04.032 · Cited by 7
Urinary proteomics for the study of genetic kidney diseases
Raimondo, F., Cerra, D., Magni, F., & Pitto, M. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1136218 · Cited by 7
The Role of Complement Activation in Diabetic Nephropathy: Current Insights and Future Directions
Kotsalas, N., Fouza, A., & Daoudaki, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238589 · Cited by 6
Analytical and Omics Approaches in the Identification of Oxidative Stress-Induced Cancer Biomarkers
Gajula, S. N. R., Bale, D. N. J., & Nanjappan, S. K. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_172-1 · Cited by 6
CE-MS in Drug Analysis and Bioanalysis
Schappler, J., González‐Ruiz, V., & Rudaz, S. L. (2016) · Wiley-VCH eBooks · doi:10.1002/9783527693801.ch6 · Cited by 8
Stanley, E., Delatola, E. I., Nkuipou‐Kenfack, E., Spooner, W., Kölch, W., Schanstra, J. P., Mischak, H., & Koeck, T. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1390-1 · Cited by 6
Self-citationRamautar, R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7643-0_12 · Cited by 6
The milk metabolome and its potential utilisation for enhanced dairy processing
Rojas‐Gómez, P., Pariyani, R., McCarthy, N. A., Bateman, L. M., O’Mahony, J. A., & O’Callaghan, T. F. (2025) · International Journal of Dairy Technology · doi:10.1111/1471-0307.70058 · Cited by 7
Yang, M., Yang, J., Liu, R., Chen, L., Chen, D., He, Y., Li, Y., Wang, H., Tang, K., Hu, Z., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02306 · Cited by 5
Clinical Proteomics in Kidney Disease: From Discovery to Clinical Application
Pejchinοvski, M., & Mischak, H. (2017) · PRILOZI · doi:10.2478/prilozi-2018-0005 · Cited by 5
Self-citationCapillary Electrophoresis-Mass Spectrometry for Proteomics
Martelli, C., & Desiderio, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809375-7.00014-9 · Cited by 6
Peptidomics and Capillary Electrophoresis
Štěpánová, S., & Kašička, V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-77252-9_5 · Cited by 3
Witkiewicz, I. M., & Neering, H. (1981) · PubMed · Cited by 2
Reddy, P., Pontillo, C., Jankowski, J., & Mischak, H. (2018) · Wiley eBooks · doi:10.1002/9781119183952.ch7 · Cited by 1
Self-citationCE-MS for Clinical Proteomics and Metabolomics: Strategies and Applications
Ramautar, R., & Britz‐McKibbin, P. (2016) · Wiley-VCH eBooks · doi:10.1002/9783527693801.ch11 · Cited by 1
Analytical and Omics Approaches in the Identification of Oxidative Stress-Induced Cancer Biomarkers
Gajula, S. N. R., Bale, D. N. J., & Nanjappan, S. K. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_172 · Cited by 1
Banni, G. A. H. D. (2021) · theses.fr (ABES) · doi:10.70675/c4c4fcfcze488z4115z816bz11d097001a01
Metadata
- Authors
- Pontillo, C., Filip, S., Borràs, D. M., Mullen, W., Vlahou, A., & Mischak, H.
- Affiliations
- Mosaiques Diagnostics and Therapeutics (Germany) (DE)
- Academy of Athens (GR)
- Université Toulouse III - Paul Sabatier (FR)
- University of Glasgow (GB)
- Corresponding author
- Mischak, Harald
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2015-03-24
- Volume
- 9
- Issue
- 3-4
- Pages
- 322-334
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W2107404088
- Cited by
- 77
- References
- 90
- Citations by year
- 2025: 4 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 8 · 2018: 12 · 2017: 8 · 2016: 15 · 2015: 9
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PROTEOMICS - CLINICAL APPLICATIONS (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Translation of novel Biomarkers for Bladder Cancer for clinical outcome prediction (FP-HEALTH-INNOVATION-2013-2, GA 601933)
- Clinical and system-omics for the identification of the Molecular Determinants of established Chronic Kidney Disease (PEOPLE-ITN-GA-2013-608332)
- Molecular Medicine for Bladder Cancer (PITN-GA-2012-317450-BCMolMed)
- Systems Biology to Identify Molecular Targets for Vascular Disease Treatment (HEALTH-2013 603288)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- capillary electrophoresis-mass spectrometry, clinical proteomics, biomarker discovery, biomarker analysis, sample preparation, sample fractionation, capillary coating, research design
- MeSH terms
- Mass Spectrometry, Reproducibility of Results, Biomarkers, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.